Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Partial purification and characterization of a novel murine factor that augments the expression of class I MHC antigens on tumor cells
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 June 1998

Partial purification and characterization of a novel murine factor that augments the expression of class I MHC antigens on tumor cells

  • Niti Puri1 &
  • R K Saxena 

Experimental & Molecular Medicine volume 30, pages 93–99 (1998)Cite this article

  • 709 Accesses

  • Metrics details

Abstract

A soluble factor which augments the expression of major histocompatibility complex class I (MHC I) antigens on a number of murine tumor cell lines, has been isolated from the culture supernatants of mixed lymphocyte reaction of spleen cells derived from C57B1/6, Balb/c and Swiss mice. The factor, termed MHC-augmenting factor (MHC-AF) has been partially purified by Sephadex G-100 column chromatography and reverse phase HPLC. MHC-AF activity is associated with an 18 kDa molecule. MHC-AF activity was resistant to pH 2.0 treatment and partially purified MHC-AF preparations did not have any activity in L929 cell/vesicular stomatitis virus (VSV) interferon bioassay system. Antibodies to IFN-γ did not block the activity of MHC-AF. These results indicate that a MHC-AF distinct from IFN-γ, is produced by mouse spleen cells undergoing a mixed lymphocyte reaction.

Similar content being viewed by others

Targeting MHC-E as a new strategy for vaccines and immunotherapeutics

Article 03 September 2025

Developing an erythrocyte‒MHC-I conjugate for cancer treatment

Article Open access 01 October 2024

Viral immune evasins impact antigen presentation by allele-specific trapping of MHC I at the peptide-loading complex

Article Open access 27 January 2022

Article PDF

Author information

Authors and Affiliations

  1. School of Life Sciences, Jawaharlal Nehru University, New Delhi, India

    Niti Puri

Authors
  1. Niti Puri
    View author publications

    Search author on:PubMed Google Scholar

  2. R K Saxena
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Puri, N., Saxena, R. Partial purification and characterization of a novel murine factor that augments the expression of class I MHC antigens on tumor cells. Exp Mol Med 30, 93–99 (1998). https://doi.org/10.1038/emm.1998.14

Download citation

  • Published: 01 June 1998

  • Issue date: 01 June 1998

  • DOI: https://doi.org/10.1038/emm.1998.14

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • MHC class I
  • IFN-g
  • MHC-AF
  • Tumor cells
  • Cytokines
Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited